Nano approaches to enhance pharmacokinetic and pharmacodynamic activity of plant origin drugs

Current Nanoscience

Volumn 5, Issue 3, 2009, Pages 344-352

  Musthaba, S M ^a   Ahmad, Sayeed ^a   Ahuja, Alka ^a   Ali, Javed ^a   Baboota, Sanjula ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Drug delivery; Herbal drugs; Liposomes; Nanoemulsion; Polymeric nanoparticles; Solid lipid nanoparticles

Indexed keywords

ACTIVE COMPONENTS; CHEMICAL DEGRADATION; DOSAGE FORMS; DRUG DELIVERY SYSTEM; HERBAL DRUG; HERBAL DRUGS; HERBAL MEDICINES; NANO-SIZED; NANOEMULSION; PHARMACOLOGICAL ACTIVITY; PLANT ORIGIN; POLYMERIC NANOPARTICLES; PROLIPOSOMES; SINGLE SPECIES; SOLID LIPID NANOPARTICLES; SYNERGISTIC ACTION; THERAPEUTIC USE; THERAPEUTIC VALUES; TISSUE MACROPHAGES;

BIOCHEMISTRY; CHEMICAL STABILITY; DRUG DELIVERY; LIPOSOMES; NANOPARTICLES; PHOSPHOLIPIDS; POLYMERS;

DRUG DOSAGE;

BABCHI OIL; BREVISCAPINE; CAMPTOTHECIN; CARBON NANOTUBE; CATECHIN; CURCUMIN; CURCUMINOID DERIVATIVE; CUSCUTA CHINENSIS EXTRACT; HERBACEOUS AGENT; HYPERICIN; LIPID NANOTUBE; LIPOSOME; NANOCAPSULE; NANOCARRIER; NANOSPHERE; NANOTUBE; PODOPHYLLOTOXIN; SILYMARIN; SOLID LIPID NANOPARTICLE; TETRANDRINE; TRIPTOLIDE; UNCLASSIFIED DRUG; VINCRISTINE;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTHRITIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TOXICITY; BONE MARROW TOXICITY; BREAST CANCER; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COLON CARCINOMA; CONDYLOMA ACUMINATUM; DIARRHEA; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CYTOTOXICITY; DRUG DEGRADATION; DRUG DOSAGE FORM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG SOLUBILITY; DRUG STABILITY; DUODENUM ULCER; DYSPNEA; EDEMA; ERYTHEMA; GASTROINTESTINAL HEMORRHAGE; HEPATOMEGALY; HERBAL MEDICINE; HUMAN; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; LUNG SMALL CELL CANCER; MACROPHAGE; MICROEMULSION; NANOEMULSION; NANOMEDICINE; NAUSEA; NEUROTOXICITY; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PARTICLE SIZE; PAW EDEMA; PHARMACODYNAMICS; PHYTOCHEMISTRY; PRIORITY JOURNAL; PSORIASIS; REPRODUCTIVE TOXICITY; REVIEW; SIDE EFFECT; SILICOSIS; SINGLE DRUG DOSE; SKIN IRRITATION; SKIN PERMEABILITY; STOMACH CANCER; SUSTAINED DRUG RELEASE; TISSUE DISTRIBUTION; UROGENITAL TRACT DISEASE; VOMITING;

EID: 70449369585     PISSN: 15734137     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341309788921453     Document Type: Review

References (49)

1. Solecki, R.S.; Shanidar, I.V. A Neanderthal flower burial in northan iraq. Science, 1975, 190, 880-881.
2. Saklani, A.; Kutty, S.K. Plant-derived compounds in clinical trials. Drug. Discov. Today, 2007, 13, 161-171.
3. Cardellina, J.H. Challenges and opportunities confronting the botanical dietary supplement industry. J. Nat. Prod., 2000, 65, 1073-1084.
4. Ilya, R.; David, R.M.; Slavko, K.; Nebojsa, I.; Alexander, P.; Nikolai, B.; Anita, B.; Diego, A.M.; Christophe, R.; Nir, Y.; Joseph, O.M.; Teresa, C.; Ira, P.; Bertold, F. Plant and human health in the twenty-first century. Trends Biotechnol., 2002, 20, 522-531.
5. Lu, C.; Lu, Y.; Chen, J.; Zhang, W.; Wu, W. Synchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix system. Eur. J. Pharm Biopharm., 2007, 66, 210-219.
6. Williamson, E.M. Synergy and other interactions in phytomedicines. Phytomedicine, 2001, 8, 401-409.
7. Kubik, T.; Bogunia-Kubik, K.; Sugisaka, M. Nanotechnology on duty in medical applications. Curr. Pharm. Biotechnol., 2005, 6, 17-33 17.
8. Sosnik, A.; Carcaboso, Á.M.; Chiappetta, D.A. Polymeric nanocarriers: new endeavors for the optimization of the technological aspects of drugs. Recent Patents Biomed. Eng., 2008, 1, 43-59 43.
9. Vasir, J.K.; Reddy, M.K.; Labhasetwar, V.D. Nanosystems in drug targeting: opportunities and challenges. Curr. Nanosci., 2005, 1, 47-64.
10. Ratnam, D.V.; Ankola, D.D.; Bhardwaj, V.; Sahana, D.K.; Kumar, M.N. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J. Control. Release, 2006, 113, 189-207. (Pubitemid 43983041)
11. Allemann, E.; Gurny, R.; Doelker, E. Drug loaded nanoparticles: preparation methods and drug targeting issues. Eur. J. Pharm. Biopham., 1993, 39, 173-191. (Pubitemid 23361352)
12. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev., 2002, 54, 631-651.
13. Yen, F.; Wu, T.; Lin, L.; Cham, T.; Lin, C. Nanoparticles formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats. Food. Chem. Toxicol., 2008, 46, 1771-1777.
14. Sahu, A.; Bora, U.; Kasoju, N.; Goswami, P. Synthesis of novel biodegradable and self-assembling methoxy poly (ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater., 2008, 4, 1752-1761.
15. Liu, M.; Dong, J.; Yang, Y.; Yang, X.; Xu, H. Anti-inflammatory effects of triptolide loaded poly (d,l-lactic acid) nanoparticles on adjuvant-induced arthritis in rats. J. Ethnopharmacol., 2005, 97, 219-225. (Pubitemid 40222021)
16. Zeisser-Labouebe, M.; Lange, N.; Gurny, R.; Delie, F. Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. Int. J. Pharm., 2006, 326,174-181. (Pubitemid 44647750)
17. Min, K.H.; Park, K.; Kim, Y.; Bae, S.M.; Lee, S.; Jo, HG.; Park, R.; Kim, I.; Jeong, S.Y.; Kim, K.; Kwon, IC. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J. Control. Release, 2008, 127, 208-218.
18. Zhang, L.; Kosaraju, S.L. Biopolymeric delivery system for controlled release of polyphenolic antioxidants. Eur. Polym. J., 2007, 4, 32956-32966
19. Zeng, X.M.; Martin, G.P.; Christopher. Preparation and in vitro evaluation of tetrandrine-entrapped albumin microspheres as an inhaled drug delivery system. Eur. J. Pharm. Biopharm., 1995, 3, 87-93.
20. El-Samaligy, M.S.; Afifi, N.N.; Mahmoud, E.A. increasing bioavailability of silymarin using a buccal liposomal delivery system: Preparation and experimental design investigation. Int. J. Pharm., 2006, 308, 140-148.
21. El-Samaligy, M.S.; Afifi, N.N.; Mahmoud, E.A. Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance. Int. J. Pharm., 2006, 319, 121-129.
22. Johnston, M.J.W.; Semple, S.C.; Klimuk, S.K.; Edwards, K.; Eisenhardt, M.L.; Leng, E.C.; Karlsson, G.; Yanko, D.; Cullis PR. Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations. Biochim. Biophys. Acta., 2006, 1758, 55-64.
23. Sou, K.; Inenaga, S.; Takeoka, S.; Tsuchida, E. Loading of curcumin into macrophages using lipid-based nanoparticles. Int. J. Pharm., 2008, 352, 287-293.
24. Fang, J.; Hwang, T.; Huanga, Y.; Fang, C. Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int. J. Pharm., 2006, 310, 131-138. (Pubitemid 43287976)
25. Lee, J.; Chungb, D.; Lee, H.G. Preparation and characterization of calcium pectinate gel beads entrapping catechin-loaded liposomes. Int. J. Biol. Macromol., 2008, 42, 178-184.
26. Zhong, H.; Deng, Y.; Wang, X.; Yang, B. Multivesicular liposome formulation for the sustained delivery of breviscapine. Int. J. Pharm., 2005, 301, 15-24. (Pubitemid 41206586)
27. Tokudome, Y.; Oku, N.; Doi, K.; Namba, Y.; Okada, S. Antitumor activity of vincristine encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcoma. Biochim. Biophys. Acta., 1996, 1279, 70-74. (Pubitemid 26067419)
28. Payne, N.I.; Timmis, P.; Ambrose, C.V.; Warel, M.D. Proliposomes: a novel solution to an old problem. J. Pharm. Sci., 1986, 75, 325-329.
29. Mayer, L.D.; Baly, M.B.; Hope, K.J.; Cullis, P.R. Techniques for encapsulating bioactive agents into liposomes. Chem. Phys. Lipids., 1986, 40, 333-345.
30. Yan-yu, X.; Yun-mei, S.; Zhi-peng, C.; I-neng, P. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs. Int. J. Pharm., 2006, 319,162-168.
31. Wong, H.L.; Bendayan, R.; Rauth, A.M.; Li, Y.; Wu, XY. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv. Drug. Deliv. Rev., 2007, 59, 491-504. (Pubitemid 47259227)
32. Tiyaboonchai, W.; Tungpradit, W.; Plianbangchang, P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm., 2007, 337, 299-306. (Pubitemid 46756048)
33. Li, Y.; Dong, L.; Jia, A.; Chang, X.; Xue, H. Preparation and characterization of solid lipid nanoparticles loaded traditional chinese medicine. Int. J. Biol. Macromol., 2006, 38, 296-299.
34. Mei, Z.; Li, X.; Wu, Q.; Hu, S.; Yang, X. The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle. Pharmacol. Res., 2005, 51, 345-351. (Pubitemid 40430808)
35. Chen, H.; Chang, X.; Du, D.; Liu, W.; Liu, J.; Weng, T.; Yang, Y.; Xu, H.; Yang, T.X. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J. Control. Release, 2006, 110, 296-306. (Pubitemid 41827483)
36. Mei, Z.; Chen, H.; Weng, T.; Yang, Y.; Yang, X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopham., 2003, 56, 189-196. (Pubitemid 37072102)
37. Lawrencea, M.J.; Reesb, G.D. Microemulsion-based media as novel drug delivery systems. Adv. Drug. Deliv. Rev., 2000, 45, 89-121. (Pubitemid 30943127)
38. Chen, H.; Chang, X.; Weng, T.; Zhaoa, X.; Gaob, Z.; Yang, Y.; Xu, H.; Yang, X. A study of microemulsion systems for transdermal delivery of triptolide. J. Control. Release, 2004, 98, 427-436. (Pubitemid 39093953)
39. Ali, J.; Akhtar, N.; Sultana, Y.; Baboota, S.; Ahuja, A. Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia). Methods Find Exp. Clin. Pharmacol., 2008, 30, 1-9.
40. Wang, X.; Jiang, Y.; Wang, Y.W.; Huang, M.T.; Hoa, C.T.; Huang, Q. Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions. Food Chem., 2008, 108, 419-424.
41. Chen, H.; Chang, X.; Weng, T.; Zhaoa, X.; Gaob, Z.; Yang, Y.; Xu, H.; Yang, X. A study of microemulsion systems for transdermal delivery of triptolide. J. Control. Release, 2004, 98, 427-436. (Pubitemid 39093953)
42. Foldvari, M.; Bagonluri, M. Carbon nanotubes as functional excipients for nanomedicines: I. pharmaceutical properties. Nanomedicine: NBM., 2008, 4, 173-182.
43. Thassu, D.; Deleers, M.; Pathak, Y. Nanoparticulate drug delivery systems, drug and pharmaceutical sciences; Informa healthcare: New York, 2007; Vol. 166.
44. Foldvari, M.; Bagonluri, M. Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues. Nanomedicine: NBM., 2008, 4, 183-200.
45. Kayser, O.; Lemke, A.; Hernández-Trejo, N. The impact of nanobiotechnology on the development of new drug delivery systems. Curr. Pharm. Biotechnol., 2005, 6, 3-5. (Pubitemid 40246748)
46. Zhou, Y. Patenting activity in synthesis of lipid nanotubes and peptide nanotubes. Recent Pat. Nanotechnol., 2007, 1, 21-28.
47. Watanabe, M.; Kawano, K.; Toma, K.; Hattori, Y.; Maitani, Y. In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin. J. Control. Release, 2008, 127, 231-238.
48. Li, Y.; Dong, L.; Jia, A.; Chang, X.; Xue, H. Preparation and characterization of solid lipid nanoparticles loaded traditional chinese medicine. Int. J. Biol. Macromol., 2006, 38, 296-299.
49. Zeng, X.M.; Martin, G.P.; Marriott, C. The preparation and in vitro evaluation of tetrandrine-entrapped albumin microspheres as an inhaled drug delivery system. Eur. J. Pharm. Sci., 1995, 3, 87-93.